- Review
Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors
- Joline S. J. Lim and
- David S. P. Tan
Poly-(ADP-ribose) polymerase (PARP) inhibitors act through synthetic lethality in cells with defects in homologous recombination (HR) DNA repair caused by molecular aberrations such as BRCA mutations, and is approved for treatment in ovarian cancer,...

